Indoleamine 2,3-dioxygenase-1 (IDO1) expression by childhood acute myeloid leukemias inhibits T-cell production of IFN-γ and confers an unfavorable prognosis

Por Rutella, Sergio, Folgiero, Valentina, Filippini, Perla, Bertaina, Valentina, Masetti, Riccardo, Zecca, Marco, Pira, Giuseppina Li, Torelli, Giovanni F, Testi, Anna Maria, Bertaina, Alice, Pession, Andrea, Locatelli, Franco
Publicado em 2013

Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells

Por Torelli, Giovanni F., Peragine, Nadia, Raponi, Sara, Pagliara, Daria, De Propris, Maria S., Vitale, Antonella, Bertaina, Alice, Barberi, Walter, Moretta, Lorenzo, Basso, Giuseppe, Santoni, Angela, Guarini, Anna, Locatelli, Franco, Foà, Robin
Publicado em 2014

Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia

Por Folgiero, Valentina, Goffredo, Bianca M., Filippini, Perla, Masetti, Riccardo, Bonanno, Giuseppina, Caruso, Roberta, Bertaina, Valentina, Mastronuzzi, Angela, Gaspari, Stefania, Zecca, Marco, Torelli, Giovanni F., Testi, Anna M., Pession, Andrea, Locatelli, Franco, Rutella, Sergio
Publicado em 2013

A good manufacturing practice method to ex vivo expand natural killer cells for clinical use

Por Torelli, Giovanni F., Rozera, Carmela, Santodonato, Laura, Peragine, Nadia, D’Agostino, Giuseppina, Montefiore, Enrica, Napolitano, Maria R., Monque, Domenica M., Carlei, Davide, Mariglia, Paola, Pauselli, Simona, Gozzer, Maria, Bafti, Mahnaz Shafii, Girelli, Gabriella, Guarini, Anna, Belardelli, Filippo, Foà, Robin
Publicado no Blood Transfus (2015)